Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. drug discovery
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Drug Discovery Articles & Analysis

398 news found

BC Platforms enhances data analytics capabilities with NVIDIA accelerated computing

BC Platforms enhances data analytics capabilities with NVIDIA accelerated computing

BC Platforms has embedded NVIDIA accelerated computing into BC Mosaic, its trusted research environment, enabling faster GPU-powered analytics and AI-led analyses across clinical, multi-omics, and real-world data to support precision medicine and accelerated drug development.NVIDIA integration in BC MosaicNVIDIA technology is now natively available within BC Mosaic, providing ...

ByBC Platforms


Ace Therapeutics Releases BBBporter™ Technology Platform to Overcome the Challenges of Brain Drug Delivery

Ace Therapeutics Releases BBBporter™ Technology Platform to Overcome the Challenges of Brain Drug Delivery

The BBB is a highly selective barrier that protects the brain from harmful substances but also blocks over 98% of small-molecule drugs and virtually all large-molecule therapeutics from entering the CNS. ...

ByAce Therapeutics


Accepting new applications for ACE program 2025

Accepting new applications for ACE program 2025

Through this program, investigators or technology transfer offices with potential oncology drug candidates, in the early discovery or development phases, can submit their application to POAI for consideration. The POAI platform provides data (wet lab and active ML modeling) back to researchers based on access to an otherwise unreachable number of primary patient ...

ByPredictive Oncology Inc.


Huateng Pharma Highlights the Pharmaceutical Potential of N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7)

Huateng Pharma Highlights the Pharmaceutical Potential of N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7)

Versatile compound shows promise in drug synthesis, metal chelation, antioxidant activity, and moreChangsha, China – May 22, 2025– Hunan Huateng Pharmaceutical Co., Ltd., a leading global supplier of PEG derivatives and pharmaceutical intermediates, is proud to offer high-purity N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7) to researchers and pharmaceutical developers ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Creative Diagnostics Announces Antiviral Drug Discovery Services to Accelerate Therapeutic Development

Creative Diagnostics Announces Antiviral Drug Discovery Services to Accelerate Therapeutic Development

Integrated drug discovery services combine biology, medicinal chemistry, pharmacology and other sciences with cutting-edge technology to create new therapeutic options. ...

ByCreative Diagnostics


BOC Sciences Returns to Drug Discovery Chemistry 2025, Seeking Broad Partnerships

BOC Sciences Returns to Drug Discovery Chemistry 2025, Seeking Broad Partnerships

BOC Sciences adds to its participation agenda the prestigious Drug Discovery Chemistry 2025 Conference (April 14-17, 2025), which will be a hybrid event taking place in San Diego, CA, and will offer virtual access for worldwide attendees Drug Discovery Chemistry is a heavyweight industry event. ...

ByBOC Sciences


Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing Depression-Related Behavior Tests

Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing Depression-Related Behavior Tests

This integral development aims to enhance the understanding of depressive disorders and expedite the discovery of innovative therapeutic solutions. Depression is a pervasive global health challenge that affects millions of individuals, with current treatment options often proving ineffective or inaccessible. ...

ByAce Therapeutics


CD Bioparticles Announces Enhanced Online Ordering System for Improved Customer Experience

CD Bioparticles Announces Enhanced Online Ordering System for Improved Customer Experience

Since its inception, CD Bioparticles has been committed to developing and providing cutting-edge technologies to advance drug discovery and development. To enhance the customer shopping experience and save time when placing orders, CD Bioparticles has deliberately updated the ordering system on its website to make it easier for customers to purchase all types of ...

ByCD Bioparticles


Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Development Services

“Our diagnostic development services offer tailored solutions designed to accelerate the pace of discovery in rare disease research. By providing innovative diagnostic tools and support, we empower researchers to take significant steps toward effective ...

ByProtheragen


Alfa Chemistry Expands Pharmaceutical Product Portfolio: Introducing PROTAC Building Blocks, Nucleosides, Intermediates, and APIs

Alfa Chemistry Expands Pharmaceutical Product Portfolio: Introducing PROTAC Building Blocks, Nucleosides, Intermediates, and APIs

Alfa Chemistry provides a wide variety of these intermediates which meet strict quality and safety requirements required for the drug development process. These intermediates (ammonium acids, organic acids, esters and heterocyclic compounds) allow us to innovate in drug synthesis, which in turn leads to more effective and precise drugs. ...

ByAlfa Chemistry


Role of Precision Cut Lung Slices (PCLS) In Advancing COPD Preclinical Research

Role of Precision Cut Lung Slices (PCLS) In Advancing COPD Preclinical Research

Chronic Obstructive Pulmonary Disease (COPD) is a global health burden characterized by persistent airflow limitation and progressive lung damage. Despite extensive research, translating findings from bench to bedside remains a challenge. Precision Cut Lung Slices (PCLS) have emerged as a versatile tool in COPD research, offering unique advantages for understanding disease mechanisms and ...

BySCIREQ - an emka TECHNOLOGIES Company


Ace Therapeutics Releases Cardiovascular Disease Model Development Services to Power Up Related Preclinical Research

Ace Therapeutics Releases Cardiovascular Disease Model Development Services to Power Up Related Preclinical Research

Ace Therapeutics is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide, ...

ByAce Therapeutics


Ace Therapeutics Launches Gene Therapy Development Services to Unleash Glaucoma Drug Research

Ace Therapeutics Launches Gene Therapy Development Services to Unleash Glaucoma Drug Research

As an innovative ophthalmic disease research company with a wide range of services in basic research, drug development, and preclinical studies, Ace Therapeutics has expanded its portfolio to include gene therapy solutions designed specifically to accelerate glaucoma drug discovery and development. ...

ByAce Therapeutics


Protheragen-ING Announces Lyophilized Flash-release Formulations Development Capabilities

Protheragen-ING Announces Lyophilized Flash-release Formulations Development Capabilities

Protheragen-ING has recently announced its ability to provide freeze-drying flash-release formulation development services to clients involved in drug discovery and development worldwide. Lyophilized flash-release formulations are advanced drug delivery systems that incorporate the benefits of both lyophilization and flash-release technologies. ...

ByProtheragen-ING


Protheragen-ING AI-Pharma’s AI-Powered Drug Discovery and Design Platform—A Paradigm Shift in Drug Development

Protheragen-ING AI-Pharma’s AI-Powered Drug Discovery and Design Platform—A Paradigm Shift in Drug Development

In the ever-evolving landscape of pharmaceutical research and development, the demand for innovative and efficient drug discovery methods is more pressing than ever. At the forefront of this demanding field is Protheragen-ING AI-Pharma, a contract research and development biotechnology company, offering cutting-edge solutions to researchers through its ...

ByProtheragen-ING


BOC Sciences Opens Registration for the Webinar on Peptide-Drug Conjugates (PDCs)

BOC Sciences Opens Registration for the Webinar on Peptide-Drug Conjugates (PDCs)

Kelly Bugatti, BOC Sciences is set to host an informative webinar that will delve into the latest advancements in utilizing Peptide-Drug Conjugates (PDCs) for the targeted treatment of Pulmonary Fibrosi BOC Sciences has been organizing regular webinars in the fields of life sciences, drug discovery, and chemistry. ...

ByBOC Sciences


Immune System Tissue Microarrays for Research Usage

Immune System Tissue Microarrays for Research Usage

It is a practical and effective tool for high-throughput molecular analysis of tissues, helping to identify new diagnostic and prognostic markers and targets for human cancers, with a wide range of potential applications in basic research, tumor prognosis and drug discovery. Immune System Tissue Microarrays from CD BioSciences are meticulously designed to feature ...

ByCD BioSciences


Validating The BLEO-Induced Mouse Model For Drug Discovery

Validating The BLEO-Induced Mouse Model For Drug Discovery

Developing effective treatments for IPF has been a challenge for the medical community, as the mechanisms driving this disease are complex and not fully understood. To accelerate drug discovery, animal models that closely mimic the human disease are crucial. ...

BySCIREQ - an emka TECHNOLOGIES Company


Ace Therapeutics Unveils Model Development Services to Power Up Psychiatric Drug R&D

Ace Therapeutics Unveils Model Development Services to Power Up Psychiatric Drug R&D

By leveraging its expertise and resources, the company can develop animal models, cell models, multicellular models, pharmacokinetic/pharmacodynamic modeling, biomarker discovery, and more. These model development services are designed to offer researchers the tools and resources they need to optimize drug development and maximize success rates. ...

ByAce Therapeutics


Mastering Tissue Dissociation - Episode 1 : The Heart

Mastering Tissue Dissociation - Episode 1 : The Heart

The precise tissue dissociation guaranteed by this technology preserves cellular integrity, producing high-quality suspensions essential for a variety of applications, including regenerative medicine and drug discovery. Intrigued? Find out more in our first application note in the “Mastering Tissue Dissociation” series. ...

ByBertin Technologies

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT